Never Run Out Of Buyers To Sell To.

At 100XBIO we strive to deliver 100x more data on antigen specificity of the T cells in the limited sample volume (blood, tumor, lymph nodes), and as the downstream - confirming the cells' phenotype and cytokine expression. Looking for (1) early investments,(2) R&D partners, and (3) early academia, biotech and pharma clients. We are raising $1.25M of pre-seed investment, and raised $375K. Accredited investors: welcome!
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.